MYELOMA BIOLOGY AND THERAPY-Reference-Cited by-同舟云学术

MYELOMA BIOLOGY AND THERAPY

Published:1997-02 Issue:1 Volume:11 Page:159-172
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Nishimoto Norihiro,Shima Yoshihito,Yoshizaki Kazuyuki,Kishimoto Tadamitsu

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference86 articles.

1. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: A randomized clinical trial from the Myeloma Group of Central Sweden;Ahre;Cancer Treat Rep,1984

2. Interleukin-6 in biology and medicine;Akira;Adv Immunol,1993

3. Hypercalcaemia due to all-trans retinoic acid [letter];Akiyama;Lancet,1992

4. The treatment of multiple myeloma;Alexanian;N Engl J Med,1994

5. Primary dexamethasone treatment of multiple myeloma;Alexanian;Blood,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells;Cancer Gene Therapy;2005-08-05

2. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway;Oncogene;2003-09

3. Adhesion-Mediated Intracellular Redistribution of c-Fas-Associated Death Domain-Like IL-1-Converting Enzyme-Like Inhibitory Protein-Long Confers Resistance to CD95-Induced Apoptosis in Hematopoietic Cancer Cell Lines;The Journal of Immunology;2002-03-01

4. Cytokines and Bone Remodeling;Osteoporosis;2001

5. Loss of PTEN expression leading to high Akt activation in human multiple myelomas;Blood;2000-11-15